SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-140054
Filing Date
2024-05-16
Accepted
2024-05-16 08:12:02
Documents
15
Period of Report
2024-05-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800327d8k.htm   iXBRL 8-K 30387
2 EX-10.1 d800327dex101.htm EX-10.1 21523
6 GRAPHIC g800327g0514041152450.jpg GRAPHIC 2851
  Complete submission text file 0001193125-24-140054.txt   187357

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20240507.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20240507_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20240507_pre.xml EX-101.PRE 11258
18 EXTRACTED XBRL INSTANCE DOCUMENT d800327d8k_htm.xml XML 3642
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 24953624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)